Search For "pembrolizumab"
Zumutor Biologics Announces Dosing of First Patient with ZM008, a First-in
Updated : 1 year, 9 months ago IST
Boston (Massachusetts) [US]/ Bangalore (Karnataka) [India], June 12: Zumutor Biologics Inc. "Zumutor", a Boston-based clinical stage Oncology Company developing first-in-class monoclonal antibody molecules targeting innate immunological pathways, today announced that the first patient was do
Read More
Study finds how Immunotherapy for brain cancer metastases displays clinica
Updated : 2 years, 9 months ago IST
Researchers discovered that 42 percent of patients with metastatic brain cancer benefited from the immune checkpoint inhibitor pembrolizumab in a phase 2 clinical study, with seven patients living for more than two years. The authors emphasise that these advantages must be balanced against t
Read More
Study reveals how immunotherapy treatment produces exceptional response i
Updated : 2 years, 11 months ago IST
A startling 89 per cent of desmoplastic melanoma patients in a nationwide clinical study responded to immunotherapy (pembrolizumab) alone, indicating that many patients could avoid the potential side effects of combination therapies and achieve disease control with this course of treatment.
Read More
Govt exempts import duty on drugs used for treatment of rare diseases
Updated : 2 years, 11 months ago IST
The central has fully exempted basic customs duty on the import of all drugs and food for special medical purposes and for personal use for the treatment of rare diseases.
Read More
Study finds how Pembrolizumab helps in cervical cancer treatment
Updated : 3 years, 1 month ago IST
Chemotherapy and pembrolizumab have been approved for the treatment of women with metastatic, recurring, or persistent cervical cancer whose tumours express PD-L1. Chemotherapy can be administered with or without bevacizumab. Whether pembrolizumab in this combination provides patients with a
Read More
Next-generation immunotherapy drug shows promise in some late-stage cancer
Updated : 3 years, 9 months ago IST
Ney York [US], May 27 (ANI): Initial study results prove that an experimental drug called 'nemvaleukin alfa' can be used to treat several types of late-stage cancer in some patients when used alone or in combination with another anticancer drug 'pembrolizumab.'
Read More
Immunotherapy drug strengthens head, neck cancer treatment: Study
Updated : 4 years ago IST
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Read More
Patients with high-risk local melanomas benefit from immunotherapy drug: S
Updated : 4 years, 5 months ago IST
Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Read More
Researchers analyze new drug combination to improve survival in advanced k
Updated : 5 years ago IST
Massachusetts [US], February 14 (ANI): A new clinical study published in The New England Journal of Medicine today and simultaneously presented during the American Society of Clinical Oncology (ASCO) 2021 Genitourinary Cancers Symposium claims that a drug combination of Lenvatinib plus pemb
Read More
New 'safe' immunotherapy offers hope for cancer patients with HIV
Updated : 8 years, 4 months ago IST
Washington D.C. [USA], Nov 8 (ANI): A new category of immunotherapies, called checkpoint inhibitors, appears safe to use in patients with both advanced malignancies and HIV, according to a recent study.
Read More